Articles with "hospitalization death" as a keyword



Patient Characteristics Associated With Occurrence of Preoperative Goals-of-Care Conversations

Sign Up to like & get
recommendations!
Published in 2023 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2022.55407

Abstract: Key Points Question What is the association between patient risk of hospitalization or death, measured with a Care Assessment Need (CAN) score, and occurrence of goals-of-care conversations documented with a completed Life-Sustaining Treatment (LST) Decisions… read more here.

Keywords: goals care; patient characteristics; risk hospitalization; care conversations ... See more keywords

Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19

Sign Up to like & get
recommendations!
Published in 2022 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2022.6920

Abstract: Key Points Question Is subcutaneous treatment with casirivimab and imdevimab associated with improved 28-day clinical outcomes compared with nontreatment, and is it clinically similar to intravenously administered casirivimab and imdevimab for outpatients with COVID-19? Findings… read more here.

Keywords: clinical outcomes; casirivimab; casirivimab imdevimab; hospitalization death ... See more keywords

Multimorbidity and the risk of hospitalization and death in atrial fibrillation: A population‐based study

Sign Up to like & get
recommendations!
Published in 2017 at "American Heart Journal"

DOI: 10.1016/j.ahj.2016.11.008

Abstract: Background Patients with atrial fibrillation (AF) have many comorbidities and excess risks of hospitalization and death. Whether the impact of comorbidities on outcomes is greater in AF than the general population is unknown. Methods One… read more here.

Keywords: atrial fibrillation; risk; death; hospitalization death ... See more keywords
Photo from wikipedia

Increased Risk of Hospitalization and Death in Patients with COVID-19 and Pre-existing Noncommunicable Diseases and Modifiable Risk Factors in Mexico

Sign Up to like & get
recommendations!
Published in 2020 at "Archives of Medical Research"

DOI: 10.1016/j.arcmed.2020.07.003

Abstract: Abstract Background The population in Mexico has high prevalence rates of noncommunicable diseases (NCDs). Hospitalization and death of COVID-19 patients in the countries most affected by the pandemic has been associated to chronic comorbidities. Objective… read more here.

Keywords: risk; increased risk; patients covid; hospitalization death ... See more keywords

A Multimodal Strategy to Reduce the Risk of Hospitalization/death in Ambulatory Patients with COVID-19

Sign Up to like & get
recommendations!
Published in 2022 at "Archives of Medical Research"

DOI: 10.1016/j.arcmed.2022.01.002

Abstract: Background Different interventions have been implemented worldwide for the house-hold monitoring of patients with mild COVID-19 to reduce the burden of healthcare systems and guarantee quality of care. Telephone follow up and treatment kits have… read more here.

Keywords: hospitalization death; risk; ambulatory patients; risk hospitalization ... See more keywords

SARS-CoV-2 Vaccine Effectiveness and Breakthrough Infections Among Patients Receiving Maintenance Dialysis

Sign Up to like & get
recommendations!
Published in 2022 at "American Journal of Kidney Diseases"

DOI: 10.1053/j.ajkd.2022.10.010

Abstract: Rationale & Objective SARS-CoV-2 vaccine effectiveness and immunogenicity threshold associated with protection against COVID-19 related hospitalization or death in the dialysis population is unknown. Study Design Retrospective, observational study. Setting & Participants Adult patients receiving… read more here.

Keywords: vaccine effectiveness; dialysis; covid; hospitalization death ... See more keywords

Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era

Sign Up to like & get
recommendations!
Published in 2022 at "Open Forum Infectious Diseases"

DOI: 10.1093/ofid/ofac517

Abstract: Abstract Background Monoclonal antibody (mAb) treatment is associated with decreased risk of hospitalization and death in high-risk outpatients with mild to moderate coronavirus disease 2019 (COVID-19) caused by early severe acute respiratory syndrome coronavirus 2… read more here.

Keywords: bebtelovimab; hospitalization death; bebtelovimab treatment; treatment ... See more keywords

Risk of hospitalization and death for COVID‐19 in persons with epilepsy over a 20‐month period: The EpiLink Bologna cohort, Italy

Sign Up to like & get
recommendations!
Published in 2022 at "Epilepsia"

DOI: 10.1111/epi.17356

Abstract: Data on COVID‐19 outcomes in persons with epilepsy (PWE) are scarce and inconclusive. We aimed to study the risk of hospitalization and death for COVID‐19 in a large cohort of PWE from March 1, 2020… read more here.

Keywords: persons epilepsy; death covid; hospitalization death; risk hospitalization ... See more keywords
Photo from wikipedia

Risk of hospitalization and death within 2 years after methicillin‐resistant Staphylococcus aureus (MRSA) diagnosis in persons colonized or infected with livestock and non–livestock‐associated MRSA—A nationwide register‐based cohort study

Sign Up to like & get
recommendations!
Published in 2020 at "Zoonoses and Public Health"

DOI: 10.1111/zph.12765

Abstract: Livestock‐associated methicillin‐resistant Staphylococcus aureus (LA‐MRSA) CC398 has emerged in humans throughout Europe and the USA during the last decade and is associated with the spread of LA‐MRSA CC398 in production animals. In this study, we… read more here.

Keywords: cc398; mrsa; mrsa cc398; hospitalization death ... See more keywords

Abstract 4362513: J-shaped Association of Serum Hypoxia-inducible Factor 1α Levels With Incident Heart Failure in Patients With Stable Coronary Artery Disease: The ANOX Study

Sign Up to like & get
recommendations!
Published in 2025 at "Circulation"

DOI: 10.1161/circ.152.suppl_3.4362513

Abstract: Background: Hypoxia-inducible factor-1 (HIF-1) is a heterodimeric transcription factor composed of a constitutively expressed β subunit (HIF-1β) and an oxygen-dependent α subunit (HIF-1α). HIF-1α has an important protective effect on the pathophysiology underlying coronary artery… read more here.

Keywords: hif levels; composite hospitalization; hospitalization; hospitalization death ... See more keywords

Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial.

Sign Up to like & get
recommendations!
Published in 2023 at "Circulation"

DOI: 10.1161/circulationaha.123.063901

Abstract: BACKGROUND COVID-19 (coronavirus disease 2019) is associated with heightened risks of venous and arterial thrombosis and hospitalization due to respiratory failure. To assess whether prophylactic anticoagulation can safely reduce the frequency of venous and arterial… read more here.

Keywords: hospitalization death; hospitalization; rivaroxaban; thrombotic events ... See more keywords